V okencu izberite šolo in razred v prihodnjem šolskem letu in prihranite

.
 
.

Vaccines for Pandemic Influenza

Avtor:

.
Redna cena: 252,16 €
Rok dobave: 21-28 dni
.
.
.
Količina:  
.
Strošek dostave je enoten za celo Slovenijo in znaša 2,95 €, ne glede na količino in vrsto kupljenih izdelkov.

Številni izdelki imajo oznako "brezplačna dostava", kar pomeni, da v prmeru nakupa takšnega izdelka poštnine ne boste plačali. 

Več o dostavi
Emka.si omogoča naslednje načine plačila:
  • z gotovino ob prevzemu (velja le za fizične osebe),
  • s plačilno oziroma kreditno kartico (Mastercard, Visa, ActivaMaestro, Activa, Diners, American Express),
  • s storitvijo Moneta (Mobitel in Simobil)
  • Plačilo po predračunu (pravne osebe)
  • Račun z odlogom plačila (za javna podjetja)
Več o plačilih

Pri vsakem izdelku je naveden predviden rok dostave. Glede na to katere izdelke izberete, se vam pri oddaji naročila prikaže tudi končni predviden datum dobave vašega pakete.

Večino izdelkov dostavljamo iz lastne zaloge, zato so naši dobavni roki zelo kratki.

Ko vam bomo poslali paket boste o tem obveščeni tudi po emailu. V emailu bo navedena številka vašega paketa ter povezava do Pošte Slovenije, kjer boste lahko preverili natančen status dostave.

Več o dostavi

To je spletna cena
Shrani v seznam želja
.

.

Opis



Concerns about pandemic preparedness have stimulated research activities to develop vaccines for pandemic influenza viruses, and to overcome the limitations inherent in various approaches to vaccine production and distribution. This book describes vaccine development and delivery.

The recent outbreak of disease caused by a novel H1N1 virus has focused global attention on the threat of a new influenza pandemic. Recent years have also seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans resulting in numerous fatalities. The rapid expansion in the geographic distribution of these novel viruses raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have limited antigenic relationships to the newly emerging virus strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop effective vaccines for pandemic influenza viruses, and to overcome the limitations inherent in current approaches to vaccine production and distribution.; These limitations include the use of embryonated chicken eggs as the substrate for vaccine production; which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations...more on http://springer.com/978-3-540-92164-6

Preface.- Pandemic influenza as a current threat.- Designing vaccines for pandemic influenza.- Current vaccines for seasonal influenza.- Generation and characterization of candidate vaccine viruses for pre-pandemic influenza vaccines.- Recombinant proteins produced in insect cells.- Adjuvants for pandemic influenza vaccines.- Live attenuated vaccines for pandemic influenza.- Influenza vaccines for avian species.- Development and application of avian influenza vaccines in China.- Attenuated influenza virus vaccines with modified NS1 proteins.- DNA Vaccines against Influenza viruses.- Influenza neuraminidase as a vaccine antigen.- Recombinant vectors as influenza vaccines.- Universal Pandemic Influenza Vaccines.- Influenza virus-like particles as pandemic vaccines.- Antigenic cross-reactivity among H5N1 viruses.- Transcutaneous immunization with influenza vaccines.- Self-administered microneedle patches for pandemic influenza.- Animal models for evaluation of influenza vaccines.- Immunosenescence and influenza vaccine efficacy.- Summary of recent clinical trials.- Considerations for licensure of pandemic and pre-pandemic indications in the U.S..- Strategies for Broad Global Access to Pandemic Influenza Vaccines.- Prioritization of Pandemic Influenza Vaccine: Rationale and Strategy for Decision-Making.- Subject index.
.
.
.

O avtorju - R. Compans

Obvestite me o novi knjigi tega avtorja

Želite, da vas po elektronski pošti obvestimo, ko izide nova knjiga ali ponatis katere od knjig tega avtorja?

DA - obveščajte me o novostih avtorja
.
.
.
.

Podrobnosti o izdelku

  • Obseg/št. strani: 530
  • Datum Izida:
  • Jezik: angleški
  • Vezava: Trda
  • ISBN/EAN: 9783540921646
  • Mere izdelka vxš: 23,5 x 15,5 cm
  • Založba Springer Verlag
  • Avtor:
  • Povprečna ocena:
    Ocena kupcev: 0
    (0)

Mnenja kupcev

  0  ocen:
5 zvezdice
0%
(0)
4 zvezdice
0%
(0)
3 zvezdice
0%
(0)
2 zvezdice
0%
(0)
1 zvezdica
0%
(0)
Povprečna ocena kupcev:
Ocena kupcev: 0
(0 ocen uporabnikov )
.
Ocenite izdelek s klikom na zvezdice:
 
.
.
.
.
.

Oznake kupcev o tem izdelku

Kliknite na posamezno oznako za prikaz vseh izdelkov označenih s to oznako:

Dodaj oznako:

Dodaj
.